Vigilant Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-182
| Closed | -$24K | – | 591 |
|
|
2021
Q4 | $24K | Sell |
182
-440
| -71% | -$58K | ﹤0.01% | 386 |
|
|
2021
Q3 | $70K | Sell |
622
-31
| -5% | -$3.49K | 0.01% | 229 |
|
|
2021
Q2 | $68K | Buy |
+653
| New | +$68K | 0.01% | 236 |
|
|
2018
Q4 | – | Sell |
-180
| Closed | -$10K | – | 458 |
|
|
2018
Q3 | $10K | Hold |
180
| – | – | ﹤0.01% | 400 |
|
|
2018
Q2 | $9K | Sell |
180
-165
| -48% | -$8.25K | ﹤0.01% | 418 |
|
|
2018
Q1 | $16K | Buy |
345
+165
| +92% | +$7.65K | ﹤0.01% | 319 |
|
|
2017
Q4 | $7K | Buy |
+180
| New | +$7K | ﹤0.01% | 355 |
|
|
2016
Q4 | – | Sell |
-384
| Closed | -$15K | – | 278 |
|
|
2016
Q3 | $15K | Hold |
384
| – | – | ﹤0.01% | 245 |
|
|
2016
Q2 | $13K | Buy |
+384
| New | +$13K | ﹤0.01% | 260 |
|